Company Overview

Development Stage

About the Company

Founded on December 8, 1995, Suzhou Dongrui Pharmaceutical is one of the domestic enterprises that have passed China's drug GMP certification. In 2003, it was recognized by the Ministry of Science and Technology as a "Key High-tech Enterprise of the National Torch Plan" and entered the top 100 pharmaceutical enterprises. The company is mainly engaged in the development, manufacturing, and sales of cephalosporin antibiotics and systemic specialty drugs. Cephalosporin antibiotic products include intermediates, active pharmaceutical ingredients, and powder injections. Systemic specialty drugs cover anti-allergy, cardiovascular system, digestive system, urinary system, and endocrine system, with dosage forms including tablets, capsules, and granules.

Dongrui Pharmaceutical will always be committed to the cause of human health. With a high sense of social responsibility and forward-thinking, through continuous technological innovation, it constantly provides society with safe and effective drugs, contributes to human health, and builds a top-tier Chinese pharmaceutical enterprise for investors.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Dongrui Pharmaceutical How Fast Is Hiring Growing? (56 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 15%
  • 2024: Down 21%
  • 2023: Up 510%
  • 2022: Down 91%
Dongrui Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Dongrui Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Master's 5
Note: How fast is hiring at Suzhou Dongrui Pharmaceutical Co., Ltd. growing? Dongrui Pharmaceutical2025: 55 openings (up 15%), 2024: 48 openings (down 21%), 2023: 61 openings (up 510%), 2022: 10 openings (down 91%), 2021: 114 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Dongrui Pharmaceutical Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 125%
  • 2024: Up 100%
Dongrui Pharmaceutical Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Suzhou Dongrui Pharmaceutical Co., Ltd. growing? Dongrui PharmaceuticalMaster's recruitment over the years: 2025: 9 openings (up 125%), 2024: 4 openings (up 100%), 2023: 2 openings, 2021: 1 openings.

Dongrui Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Suzhou Dongrui Pharmaceutical Co., Ltd.? Based on an analysis of Dongrui Pharmaceutical's job postings over the past year, "生物/制药/化工/环保类" demand: 18.3%, "医疗卫生/美容保健类": 8.7%, "其他(研发和技术类)": 7.9%, "机械/仪器仪表类": 7.9%, "计算机/网络/技术类": 7.9%, "科研类": 4.8%. For reference only.

Dongrui Pharmaceutical — What Are the Salaries Like? (126 records)

Manage
Dongrui Pharmaceutical Salary Overview
salary range: 4.5K - 50K, 42% of roles pay ¥8-15K
Note: salary statistics are based on 126 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Suzhou Dongrui Pharmaceutical Co., Ltd.?Dongrui Pharmaceutical42% of positions earn 8-15K, Undergraduate salary: ¥。经营管理类 average salary ¥23.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Dongrui Pharmaceutical

(More)
Are salaries high at Suzhou Dongrui Pharmaceutical Co., Ltd.? We provide: 省区经理,大区经理,操作工,分析,研究员,质量,运营,设计师,业务经理,组长,设备工,销售,qa,产品经理,分装,生产总监,电商设计,qc,临床,体系工程师. Click to view detailed salary analysis by job.

Dongrui Pharmaceutical honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Dongrui Pharmaceutical Related Industry Tags

Job Category

  • 经营管理类
    28.6% of total 28.6%
  • 销售类
    19.8% of total 19.8%
  • 生物/制药/化工/环保类
    18.3% of total 18.3%
  • 工厂生产类
    16.7% of total 16.7%

Education

  • 本科
    54% of total 54%
  • 大专
    27.8% of total 27.8%
  • 高中
    9.5% of total 9.5%
  • 硕士
    8.7% of total 8.7%

Experience

  • 不限
    36.5% of total 36.5%
  • 1-3年
    26.2% of total 26.2%
  • 5-10年
    23% of total 23%
  • 3-5年
    14.3% of total 14.3%
View Detailed Analysis

What does Suzhou Dongrui Pharmaceutical Co., Ltd. require? Who is Dongrui Pharmaceutical hiring? Dongrui Pharmaceutical recruitment: 经营管理类占比最多占28.6%,其次是销售类占19.8%. What education can get in at Dongrui Pharmaceutical? 本科占比最多占54%,其次是大专占27.8%. High education required at Dongrui Pharmaceutical? 硕士占8.7%. Work experience required at Dongrui Pharmaceutical? 不限占比最多占36.5%,其次是1-3年占26.2%. Where are the job locations at Dongrui Pharmaceutical? 苏州占比最多占84.1%,其次是北京占2.4%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 13,150万(元)
Legal Representative: 李其玲
Date Established:
Credit Code: 913205006283933800
Registered Address: 苏州吴中经济开发区民丰路268号

Partners & Suppliers

战略合作,昂利康向其供应头孢类原料药 Source
供应商 原料药及中间体销售
采购原料药用于制剂生产 Source
供应商 化学制药
苏州禾平医药向苏州东瑞制药采购头孢类药品 Source
合作客户 化学药品制剂
国药控股苏州康民医药有限公司作为药品配送商,从东瑞制药采购药品进行分销。 Source
合作客户 化学药
药物研发合作 Source
供应商 研发合作

People who follow Dongrui Pharmaceutical also follow

Dongrui Pharmaceutical Competitors (Similar Companies)

“To develop high-quality biologics that are accessible and affordable f”
“Research, development, and production of anti-tumor and surgical medic”
“Continuous innovation, safeguarding health”
制药/药业 生物制药 医药中间体 原料药
“Accelerating global biologic drug R&D processes, reducing R&D costs, a”
制药/药业 医药 医药中间体 抗生素
制药/药业 抗生素 原料药 化学制药
“Committed to the independent R&D, production, and sales of innovative ”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“Providing solutions for personalized treatment and health management”
医药 药效学研究 生物制品 生物医药
“Dedicated to the research and development of molecularly targeted drug”
“制药企业”
制药/药业 抗体 蛋白质工程 生物制药
生物医药 自身免疫疾病诊断 试剂 诊断试剂

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates